Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Journal of Cancer|April 15, 2021
Has the increase in the regional nodes evaluated improved survival rates for patients with locoregional colon cancer?Zhongyi Zhou, Hong Zhu, Wenxue Liu, et al.Radiation Oncology (London, England)|May 15, 2020
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysisDan Wang, Chongshun Liu, Yuan Zhou, et al.Journal of Cancer|June 7, 2021
A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomyYuqiang Li, Mengxiang Tian, Yuan Zhou, et al.Cancers|November 26, 2022
The Association of R-Loop Binding Proteins Subtypes with CIN Implicates Therapeutic Strategies in Colorectal CancerWenchao Zhao, Qian Pei, Yongwei Zhu, et al.European Radiology|July 14, 2021
Pre-treatment CT-based radiomics nomogram for predicting microsatellite instability status in colorectal cancerQian Pei, Xiaoping Yi, Chen Chen, et al.Journal of Cancer|October 9, 2020
Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited MetastasisYuqiang Li, Wenxue Liu, Lilan Zhao, et al.Oncotarget|August 17, 2016
Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgeryQian Pei, Hong Zhu, Fengbo Tan, et al.Journal of Experimental & Clinical Cancer Research : CR|October 11, 2015
Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathwayFengbo Tan, Hong Zhu, Yiming Tao, et al.Cancer Medicine|October 24, 2019
Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancerYuqiang Li, Wenxue Liu, Qian Pei, et al.BMJ Open|October 25, 2023
Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trialChunmei Wang, Ya-Chan Ning, Li-Po Song, et al.Pageof 7